MedPath

Clinical evaluation of wound healing: Effect of Ashwagadhadi ointment along with anantmool decoction in Chronic non-healing ulcer

Phase 2
Conditions
Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecifiedHealth Condition 2: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhereHealth Condition 3: L088- Other specified local infections of the skin and subcutaneous tissue
Registration Number
CTRI/2022/10/046593
Lead Sponsor
Dr Neelam Sajwan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. patients fulfilling the classical signs and symptoms of dushta varana.

2. Diabetic foot ulcer (when blood sugar level is controlled)

3. Post surgical wound infection

4. Traumatic infected wound

5. Perianal wound

Exclusion Criteria

1. Uncontrolled diabetic ulcer

2. Tubercular ulcer

3. Malignant ulcer

4. HIV, HBsAg, HCV and COVID-19 positive patients

5. Osteomylitic ulcer

6. Laprotic ulcer

7. Fulminating ulcer

8. Actinomycetes

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Size <br/ ><br>2. Depth <br/ ><br>3. Edges <br/ ><br>4. Under-mining <br/ ><br>5. Necrotic tissue type <br/ ><br>6. Necrotic tissue amount <br/ ><br>7. Exudate type <br/ ><br>8. Exudate amount <br/ ><br>9. Skin color surrounding wound <br/ ><br>10. Peripheral tissue edema <br/ ><br>11. Peripheral tissue induration <br/ ><br>12. Granulation tissue <br/ ><br>13. Epithelialization <br/ ><br>Timepoint: 8 weeks
Secondary Outcome Measures
NameTimeMethod
1. Size <br/ ><br>2. Depth <br/ ><br>3. Skin color surrounding wound <br/ ><br>4. Granulation tissue <br/ ><br>5. Epithelialization <br/ ><br>Timepoint: 4 weeks
© Copyright 2025. All Rights Reserved by MedPath